TABLE 2.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants confirmed by whole genome sequencing.

Study participantsa	Type of infectionb	Collection date	Cladec	Pango lineagec	GenBank accession
VX131	symptomatic BTI	12/20/2021	21K (Omicron)	BA.1.1.2	ON103223
VX29	symptomatic BTI	12/20/2021	21K (Omicron)	BA.1.1	ON103174
VX24	reinfection	2/3/2022	21K (Omicron)	BA.1.1	ON103202
VX20	symptomatic BTI	N/A	N/A	N/A	N/A
VX24	asymptomatic BTI	N/A	N/A	N/A	N/A

^aFor time course of the study participants refers to Figure 2.

^bBTI: breakthrough infection, N/A: not available.

^cWhole genome sequencing of SARS-CoV-2 variants was conducted from available RT-PCR positive nasal swab samples of BTIs and reinfection.